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 The cultivation of genetically modified (GM) crops in the European Union (EU) remains a highly 
polemic issue after many years of research, practical experience, and extensive discussions. The only GM 
crop event that is currently authorised for cultivation in the EU is the insect-resistant maize `MON810´, 
which was authorised in 1998 
(http://ec.europa.eu/food/dyna/gm_register/gm_register_auth.cfm?pr_id=11). The GM potato variety 
`Amflora´ with improved tuber starch composition was approved for cultivation in 2010 (original 
approval document: https://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:053:0015:0018:EN:PDF; comprehensive 
overview of the Amflora case: 
http://www.europarl.europa.eu/RegData/bibliotheque/briefing/2010/100028/LDM_BRI(2010)100028_RE
V2_EN.pdf), however the authorisation for this crop was later withdrawn (press release on the annulation 
of the Amflora approval: https://curia.europa.eu/jcms/upload/docs/application/pdf/2013-
12/cp130160en.pdf). One of the main reasons that not more GM crops are authorised for cultivation in the 
EU is that a regulatory gridlock persists in the authorisation procedure, with a recurring inability to reach 
a qualified majority for either approval or rejection in the designated committee [1]. 
Several EU member states experience domestic pressure from various stakeholders and/or the public 
against the adoption of GM crops by farmers within their territories [2,3,4,5]. A new piece of legislation 
was therefore developed by the European Commission (EC, Brussels), resulting in the Directive (EU) 
2015/412 (see http://data.europa.eu/eli/dir/2015/412/oj) being adopted by the European Parliament (EP) 
in 2015. This Directive gives the member states the possibility to restrict or prohibit the cultivation of 
authorised GM crops in their territory. The request to exclude a particular GM event from cultivation on 
all or part of the territory may be communicated to the EC prior to decision (after risk assessment), or 
after authorisation decision provided that the cultivation restriction is in conformity with the EU law, 
reasoned, proportional and non-discriminatory as well as based on certain compelling grounds (for 
examples of compelling grounds, see Article 26b(3) of Directive 2015/412/EC). To date, 17 member 
states and two autonomous regions have used this possibility for one or more GM events; namely Austria, 
Bulgaria, Croatia, Cyprus, Denmark, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, 
Luxembourg, Malta, the Netherlands, Poland, Slovenia and the regions Wallonia (Belgium) and Northern 
Ireland, Wales and Scotland (United Kingdom) (see 
http://ec.europa.eu/food/plant/gmo/authorisation/cultivation/geographical_scope_en). 
In parallel to the development of Directive 2015/412, the EC also proposed an analogous mechanism of 
opt-out from import of GM food and feed. However, this option was rejected by a large majority in the 
EP (see https://oeil.secure.europarl.europa.eu/oeil/popups/summary.do?id=1409673&t=e&l=en). This 
illustrates a paradox for GM crops in the EU, as 62 different GM products, having passed the risk 
assessment of the European Food Safety Authority (EFSA) and been authorised for food and feed use (as 
of February 2019, see GMO registry at 
https://webgate.ec.europa.eu/dyna/gm_register/index_en.cfm), are entering the EU as food and feed 
but cannot be cultivated. 
While it is true that several EU member states have already adopted opt-out measures within their 
territories, it is also a fact that some member states are in favour of authorising the cultivation of certain 
GM crops given a positive risk assessment by EFSA, as judged by the voting pattern in the Regulatory 
Committee 2001/18/EC (Committee for the adaptation to technical progress and implementation of the 
directive on the deliberate release into the environment of genetically modified organisms). We have 
therefore proposed a mechanism that would allow EU member states to take decisions individually on the 
authorisation (“opt in”) of cultivation of GM crops, given a positive risk assessment by EFSA [6]. The 
response received from various stakeholders (colleagues, policy makers, media, the public, etc.) has been 
by far mostly positive (a selection of web links is available as supplementary material). However, many 
questions have also been raised about the implementation. Accordingly, there is a need to further 
elaborate on the various alternatives for implementing such an opt-in mechanism as well as to discuss the 
implications in a broader context. We here describe two main scenarios for implementing a national opt-
in mechanism for the cultivation of GM crops given the current EU legislation. 
 
Two scenarios 
In the first scenario (Fig. 1A), the initial steps of the collective authorisation procedure remain exactly as 
today. After EFSA has delivered the risk assessment, the EC drafts a first decision which is subject to 
voting in the Regulatory Committee 2001/18/EC. In case a qualified majority is not reached either in 
favour of or against authorisation, the proposed opt-in mechanism enters into force, allowing individual 
member states to take a national decision to authorise the cultivation of the GM event in question. This 
scenario could eliminate the need for the remaining part of the collective procedure, such as the 
subsequent voting in the Appeal Committee. In case a qualified majority votes against the EU-wide 
authorisation of a GM event, the opt-in mechanism would not be available. The current opt-out 
mechanism through Directive 2015/412 remains available together with the safeguard clause (Article 23) 
of Directive 2001/18/EC (http://data.europa.eu/eli/dir/2001/18/2018-03-29), just as today, if there is a 
qualified majority voting for EU-wide authorisation of a GM event. 
In the second scenario (Fig. 1B), the risk assessment is also kept under EFSA, but a positive assessment 
by EFSA means that the event would be immediately available for opt-in by the national competent 
authority in each member state. This scenario could eliminate the need for the entire collective 
authorisation procedure, in which case the opt-out mechanism and the safeguard clause would be 
rendered ineffectual as member states can instead simply refrain from opting in. 
Without favouring any of these two projected scenarios, we estimate that the first one described may be 
the more realistic in terms of political viability as well as being more in line with the overall EU 
principles. This scenario would maintain a certain degree of harmonisation within the EU while at the 
same time providing the member states with more discretionary power whenever comitology in this 
context fails to deliver a decision based on qualified majority. Maintaining an initial degree of 
harmonisation in the risk management of GM crops would also underline the importance of a collective 
risk assessment procedure as managed by EFSA. The first scenario would also, in a less disruptive way, 
re-establish the balance in subsidiarity that was distorted in 2015 with the opt-out mechanism. As member 
states have the right to opt out from GM crop cultivation they should also have the corresponding right to 
opt in. For countries that are currently cultivating EU-authorised GM crops (such as Spain cultivating the 
insect-resistant MON810 maize [7]), it may also be more politically sensitive to take national opt-in 
decisions that may go against the policies of neighbouring countries (such as France that has opted out of 
cultivation of MON810) than to rely on EU-wide authorisation. 
The second scenario is attractive in its simplicity. Such a procedure would provide a higher degree of 
depoliticisation at the EU level in the risk management of GM crops, while it would facilitate decisions 
based more narrowly on scientific knowledge and evidence for countries that do not experience a high 
level of opposition against the cultivation of GM crops. Scientific risk assessment is undertaken by EFSA 
at the EU-wide level without political considerations. Instead, political risk management decisions are 
transferred to the national level where local considerations can be weighed unencumbered by any prior 
position taken by the Regulatory Committee 2001/18/EC and signals delivered therein by individual 
member states. 
 
Issues to address 
There are some issues related to legal matters, procedural details and trade that would need to be 
addressed regarding a national opt-in mechanism for GM crop cultivation. Both scenarios for an opt-in 
mechanism would apply only to the cultivation of GM crops. Therefore the effect on trade and the EU 
internal market for food and feed products will be limited as access of the resulting products to the market 
will remain covered by the EU-wide regime of Regulations (EC) 1829/2003 and (EC) 1830/2003 on the 
authorisation of GM food and feed. 
A reasonable expectation is that varieties with GM events other than MON810 could be included in 
national catalogues of agricultural plant varieties and hence available for agricultural production in some 
EU member states. The consequences in terms of cross-border drift may therefore be exacerbated as a 
member state opting in for a particular GM event may have neighbouring member states that have not 
opted in (in either of the two scenarios described above). We would envisage that the same provisions that 
are included in the opt-out Directive would apply. There, the member state in which GM crops are 
cultivated is responsible for taking appropriate measures in border areas of their territory to avoid possible 
cross-border drift into the neighbouring member state(s) in which the cultivation of those GM crops is not 
authorised. 
Specific to the second scenario, it needs to be established whether the right to request further information 
from EFSA, after delivery of the assessment, should lie with the EC (as today) or with the member states. 
Another detail that may also need to be addressed is the development of a procedure whereby the 
applicant, or any other, can approach any member state in addition to the one where the application was 
filed initially, in order to trigger an opt-in decision (i.e. after positive EFSA assessment, and in any of the 
two scenarios described above). 
 
An unorthodox solution? 
A national opt-in mechanism for GM crops may not fit readily with the EU internal market philosophy. 
However, the very distinct political context of cultivation of GM crops in the EU justifies to look for 
unorthodox solutions. Besides, also the opt-out mechanism introduced by Directive 2015/412 has been 
characterised as atypical in terms of the EU internal market policy [8,9]. As the current implementation of 
the EU legislation arguably does not fulfil the criteria of legal certainty, non-discrimination and scientific 
adaptability [10], we suggest that the proposed opt-in mechanism, in any of the two scenarios described 
above, would provide for a more balanced regulatory setting particularly as it would facilitate science-
based considerations in the implementation in certain member states. 
We therefore encourage the EC to launch an initiative whereby a wide range of stakeholders is invited to 
discuss this proposal to amend the EU GMO regulatory framework and to bring these issues forward at a 
high political level in the EU. Article 2 of Directive 2015/412 states that the EC shall present, no later 
than 3 April 2019, a report to the EP and the Council regarding the use the member states made of the 
opt-out mechanism, possibly accompanied by any legislative proposals the EC considers appropriate. It is 
therefore now high time for the EC to consider drafting a legislative proposal complementing the opt-out 
mechanism with others such as the opt-in discussed here. We are looking forward to such an initiative and 
are available should any political or non-political stakeholder on the EU arena wish to further discuss and 
develop the concept of a national opt-in mechanism for the cultivation of GM crops in the EU. 
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Figure legend 
Figure 1. Two scenarios for how to modify the existing authorisation procedure in order to provide for a 
national opt-in mechanism for the cultivation of genetically modified (GM) crops. (A) If Regulatory 
Committee 2001/18/EC fails to deliver a decision based on qualified majority, the opt-in mechanism 
enters into force. (B) The opt-in mechanism enters into force immediately after a positive risk assessment 
by the European Food Safety Authority (EFSA), and this could eliminate the need for the entire collective 
authorisation procedure. The figure is adapted and modified from the European Commission (EC), 
https://ec.europa.eu/food/sites/food/files/plant/docs/gmo_auth_decision-making-process.pdf. The 
modifications are in red, with lines indicating added details and crosses indicating superseded existing 
details in the decision-making procedure. 
 

